Janssen to Showcase New Insights and Commitment to Accelerating Hope and Healing for Serious Mental Illness at Psych Congress 2023
Key analyses examine long-term safety and efficacy of medicines for treatment-resistant depression and schizophrenia TITUSVILLE, N.J., Sept. 5, 2023 /PRNewswire/ — The Janssen Pharmaceutical Companies of Johnson & Johnson will showcase data from its neuropsychiatry portfolio at Psych…
Comments Off on Janssen to Showcase New Insights and Commitment to Accelerating Hope and Healing for Serious Mental Illness at Psych Congress 2023